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Abstract
Data sources  Experimental investigation.
Study design  A retrospective review to evaluate the use of a 
negative-pressure otolaryngology viral isolation drape (NOVID) system 
to reduce cross-infection through aerosol. The apparatus consists of a 
plastic drape suspended over the surgical field in the head and neck 
region with a smoke evacuator suction placed inside the chamber with 
an ultra-low penetrating air (ULPA) efficiency rating and a fluid suction 
high-efficiency particulate air (HEPA) filter compartment. Spread 
of patient secretions and droplet formation was evaluated using 
1% fluorescein dye in 10 ml of normal saline and ultraviolet light. 
The dye was applied topically in the nasal cavity and nasopharynx 
preoperatively and intraoperatively prior to the use of instruments 
such as micro-debrider, electrocautery and high-speed drilling. 
Following completion of the surgical procedure, an ultraviolet Wood’s 
lamp was used to evaluate the presence of droplets on the surgical 
drapes and surgical gowns of the operating team.
Results  The study sample consisted of four patients who underwent 
endonasal endoscopic surgical procedures; two of these patients 
required concurrent endoscopic sinus surgery. A micro-debrider was 
used in three cases; electrocautery in three cases, while a high-speed 
drilling was employed in two cases. Presence of fluorescein was 
identified around the patients’ nares; on the chest wipe and instrument 
tray in all four patients. Dye contamination was noted on the gauze 
placed over the smoke evacuator (two cases of skull base surgery); no 
fluid droplets were identified beyond the nares or the smoke evacuator 
(two cases of sinus surgery). However, fluid contamination was 
identified underneath barrier several centimetres away from the nares 
(one case of trans-sphenoidal surgery). Droplets were also identified 
on the surgeon’s gown in the abdominal region in all cases and on 
the arm region in one case. In one case, droplets were also identified 
on the abdominal region of the nurse, but this was attributed to cross 
contamination from surgical gauze and instruments. 
Conclusions  This retrospective study provides preliminary data on 
aerosol and droplet contamination during endonasal and transoral 
surgery performed under a negative pressure isolation drape system. 
Although the authors did not screen patients for SARS-CoV-2, they 
propose smoke evacuator ULPA filter attachment is appropriate to 
capture particles down to 0.1 microns including SARS-CoV-2 which is 
0.125 microns. It would be helpful to see direct evidence to support 
this claim in future studies. The authors have not provided details 
regarding set-up time and training requirements for effective application 
of the isolation drape apparatus or the associated costs etc. It would 
have also been helpful if the authors could comment on any potential 
difficulties in undertaking the surgical procedure with the isolation 
system in place. The sample size is limited to four patients and variations 
in the magnitude and extent of aerosol contamination needs to be 
investigated further before drawing any conclusions. Although unlikely, 
this study design did not capture the presence of aerosol/droplets in the 
air within the operating room which may follow removal of the isolation 
drape system or from exposed surgical instruments. Notwithstanding 
the limitations of the design, negative-pressure aspiration of air under 
a chamber barrier is likely to minimise the contamination from aerosol 
and droplet during endonasal and transoral surgery.
Commentary
The coronavirus disease (COVID-19) caused by the novel 
coronavirus (SARS-CoV-2) has had an unprecedented impact 
on people across the globe. Even the most advanced healthcare 
systems in the world are still battling to deal with the challenges 
of COVID-19 and no single strategy to limit the spread of this 
pandemic appears to be sustainable. COVID-19 has posed serious 
tests for the political leadership across the globe due to the 
financial and social fallout and also exposed the vulnerabilities 
of modern healthcare infrastructures. The death rate from 
COVID-19 in the Western world including the USA, UK, France, 
Italy, and Spain etc, has been alarming1 and has raised questions 
regarding our preparedness for managing pandemics.
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Practice points
• For now practitioners should focus on emergency and preventive 
dental care as evidence-based clinical protocols are needed prior 
to commencing invasive dental procedures
• Dental surgeries represent a potentially high-risk clinical 
environment and dental professionals must follow the most 
updated national and international guidelines in letter and spirit 
to protect themselves as well as their staff, patients, and the 
general public from further spread of COVID-19
• Additional costs related to PPE, staff training, and the investment 
to improve clinical environment coupled with low rates of 
patient turn-over will have a knock-on effect on the financial 
resources of dental businesses. Therefore, governments and 
healthcare bodies must be urged to come up with concrete 
strategies to support the dental profession and keep dental 
practices financially viable
• Finally, dental professionals should not remain at the receiving 
end of cross infection control guidelines and should explore 
appropriate platforms to actively participate in research aimed 
at informing evidence-based protocols to limit the spread of 
COVID-19 in dental environments.
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Unsurprisingly, COVID-19 is the prime focus of rapid medical 
research since the beginning of the current year and tremendous 
progress is being made as we try to unravel various facets of this 
pandemic. COVID-19 has taken medical scientists by surprise and 
the urgency to produce scientific evidence has outpaced existing 
expertise and systems. Besides social distancing measures and vaccine 
development, medical research is currently exploring the use of 
existing drugs to manage COVID-19. Amongst several medicines with 
the potential to hasten recovery from COVID-192 Remdesivir has 
shown some positive results. However, like with many other drugs, 
further adequately powered trials and meta analyses are required 
before it can be recommended for widespread use in clinical practice.3
The eventual goal in the fight against COVID-19 is the 
development of a vaccine and a large number of human trials 
have already been rolled out. COVID-19 is an RNA virus and like 
flu viruses, it is more prone to changes and mutations compared 
to DNA viruses. Recent research highlights the diversity of SARS-
CoV-2 strains and co-circulation of different clades in different 
countries. Different genetic lineages within different clades 
have been observed.4 Further research is required to understand 
if reinfections after recovery are possible, and how potential 
mutations could affect the vaccines under development? 
Uncertainties also exist regarding the degree and nature of the 
immunity required for protection from COVID-19 and whether 
exposure to COVID-19 can confer herd immunity?5
The novel coronavirus (SARS-CoV-2) has been found in 
nasopharyngeal secretions as well as saliva. Spread of infection is 
mainly through respiratory droplets and direct contact with infected 
individuals and inanimate objects.6 Critically, SARS-CoV-2 can 
spread through aerosols generated during dental procedures and 
can not only spread for considerable distances but also may remain 
suspended in the air for several hours rendering the dental surgery 
environment as a high risk area for nosocomial spread.7 
Current recommendations on providing dental care are largely 
based on expert opinion and a combination of direct and indirect 
evidence. Until the development and delivery of an effective 
COVID-19 vaccine, dental care for patients is limited to emergency 
treatment in most developed countries. At present, it is advisable 
to triage patients using remote consultations. Face-to-face 
consultation may be provided to a select group of patients after 
appropriate risk assessment. Appropriate physical and temporal 
separation measures should be implemented during face-to-face 
consultations and adequate time should be reserved for set-up, 
clearance, and decontamination of the surgery between patients.8 
Global protocols for clinical dentistry during COVID-19 show 
some geographic variations but there is a broad-based consensus 
on observing excellent hand hygiene and the use of appropriate 
personal protective equipment (PPE). The recommended PPE 
includes fluid-resistant gowns; gloves; filtering face piece respirator 
(FFP3) or N95 masks; and appropriate eye protection.9 Additional 
measures which have been suggested during operative procedures 
include effective use of high-volume suction devices; rubber dam 
isolation; adjunct chemotherapeutic agents mouth rinse with 0.2% 
povidone-iodine or 0.5–1% hydrogen peroxide may also be utilised 
preoperatively to reduce the viral load in the oral cavity.10,11
The use of NOVID system offers promise to limit contamination 
from aerosol during surgical procedures performed under general 
anaesthesia in operating theatre environments. Although use of this 
device on conscious patients in dental practice settings is unlikely in 
its current form, it opens doors to innovation in the development 
of barrier systems. In any case, dentists may benefit from evaluating 
the spread on aerosol during operative dentistry by using fluorescein 
dye and ultraviolet (UV) light as identified in this study.
Given our current understanding, COVID-19 may be around for 
the coming months or even years, and is likely to influence the 
provision of dental care in more ways than one. The best-case scenario 
is development of an effective vaccine and coupled with universal 
precautions, life in dentistry may return to normal. Until then, we are 
likely to be presented with a plethora of strategies and measures aimed 
at minimising the spread of COVID-19 in clinical dental settings. 
These may include innovations in PPE; barrier devices to minimise 
aerosol contamination; air purification systems; anti-viral adjuncts; 
chairside screening for COVID-19 in saliva; and modifications in 
clinical techniques, to name a few. Undoubtedly, commercial players 
in the dental market will be interested to exploit these business 
opportunities as dentistry attempts to resume. Therefore, dental 
professionals must make informed choices supported by scientific 
evidence. On the plus side, COVID-19 presents an opportunity for 
dental professionals to diversify their career interests and explore their 
research potential through engagement with relevant research forums 
and platforms. Cross infection protocols in dentistry are likely to 
undergo rapid evolution and dental professionals must contribute to 
this process rather than wait to be told what to do!
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